Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Murri

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2006
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the Italian version of assessment of body change and distress questionnaireG Guaraldi, G Orlando, R Murri, et al.
AIDS Care|September 27, 2003
Determinants of health-related quality of life in HIV-infected patientsR Murri, M Fantoni, C Del Borgo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitorsR Murri, M Fantoni, C Del Borgo, et al.
Journal of Global Antimicrobial Resistance|September 24, 2020
Italian young doctors' knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional surveyF Di Gennaro, C Marotta, M Amicone, et al.
Journal of Neurovirology|August 23, 2001
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational studyA De Luca, M L Giancola, A Ammassari, et al.
The Journal of Infectious Diseases|September 9, 2000
The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathyA De Luca, M L Giancola, A Ammassari, et al.
AIDS (London, England)|November 4, 2000
Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathyA De Luca, M L Giancola, A Ammassari, et al.
Infection|July 10, 2020
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumabA Cingolani, A M Tummolo, G Montemurro, et al.
Journal of Neurovirology|August 23, 2001
Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART eraA Antinori, A Ammassari, M L Giancola, et al.
The Journal of Hospital Infection|October 19, 2025
Economic impact of surgical site infection prevention across surgical units at Gemelli University Hospital: insights from a point prevalence surveyM G Cacciuttolo, M L Specchia, M Bonacquisti, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2006
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the Italian version of assessment of body change and distress questionnaireG Guaraldi, G Orlando, R Murri, et al.
AIDS Care|September 27, 2003
Determinants of health-related quality of life in HIV-infected patientsR Murri, M Fantoni, C Del Borgo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitorsR Murri, M Fantoni, C Del Borgo, et al.
Journal of Global Antimicrobial Resistance|September 24, 2020
Italian young doctors' knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional surveyF Di Gennaro, C Marotta, M Amicone, et al.
Journal of Neurovirology|August 23, 2001
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational studyA De Luca, M L Giancola, A Ammassari, et al.
The Journal of Infectious Diseases|September 9, 2000
The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathyA De Luca, M L Giancola, A Ammassari, et al.
AIDS (London, England)|November 4, 2000
Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathyA De Luca, M L Giancola, A Ammassari, et al.
Infection|July 10, 2020
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumabA Cingolani, A M Tummolo, G Montemurro, et al.
Journal of Neurovirology|August 23, 2001
Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART eraA Antinori, A Ammassari, M L Giancola, et al.
The Journal of Hospital Infection|October 19, 2025
Economic impact of surgical site infection prevention across surgical units at Gemelli University Hospital: insights from a point prevalence surveyM G Cacciuttolo, M L Specchia, M Bonacquisti, et al.
Pageof 8